Lumend

Redwood City, United States Founded: 1996 • Age: 30 yrs Acquired By Cordis
Catheter-based technologies for crossing chronic vascular occlusions are developed.
Annual revenue - Latest available
Total funding $30.0M 4 rounds
Employees - Tracked headcount
Investors 7 Known backers
Products - Services tracked
Competitors 11 Brand Intelligence

About Lumend

Lumend is a company based in Redwood City (United States) founded in 1996 by Matt Selmon and John Simpson was acquired by Cordis in September 2005. Lumend has raised $30.05 million across 4 funding rounds from investors including Cordis, CHL Medical Partners and Morgenthaler. Lumend operates in a competitive market with competitors including Cardiovascular Systems, Contego Medical, AngioScore, Echopoint Medical and Shape Memory Medical, among others.

  • Headquarter Redwood City, United States
  • Founders Matt Selmon, John Simpson
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $30.05 M (USD)

    in 4 rounds

  • Latest Funding Round
    $2 M (USD), Series D

    Aug 04, 2005

  • Investors
    Cordis

    & 6 more

  • Employee Count
    Employee Count
  • Acquired by
    Cordis

    (Sep 28, 2005)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Lumend

Lumend has successfully raised a total of $30.05M across 4 strategic funding rounds. The most recent funding activity was a Series D round of $2 million completed in August 2005. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 4
  • Last Round Series D — $2.0M
  • First Round

    (09 Jan 2003)

  • Investors Count 6
Date Amount Transaction Name Valuation Lead Investors Investors
Aug, 2005 Amount Series D - Lumend Valuation

investors

Jun, 2005 Amount Series D - Lumend Valuation

investors

Feb, 2005 Amount Series D - Lumend Valuation

investors

Investors in Lumend

Lumend has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Cordis, CHL Medical Partners and Morgenthaler.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Early stage healthcare services investments are facilitated by CHL.
Founded Year Domain Location
Venture capital and private equity investment firm
Founded Year Domain Location
-
Founded Year Domain Location

Investments & Acquisitions by Lumend

Investments

Financial Statements - Lumend

Lumend Comparisons

+
Add Comparison
Available on Premium

Competitors of Lumend

Lumend operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cardiovascular Systems, Contego Medical, AngioScore, Echopoint Medical and Shape Memory Medical, among others.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Devices for treating peripheral and coronary vascular disease are developed.
domain founded_year HQ Location
Provider of vascular stenting with embolic protection for both coronary and peripheral vasculature
domain founded_year HQ Location
Scoring balloon catheters for coronary and peripheral angioplasty are developed.
domain founded_year HQ Location
Smart devices for monitoring coronary artery disease are developed.
domain founded_year HQ Location
Embolization devices are developed using Shape Memory Polymer foams.
domain founded_year HQ Location
Developer a system for venous arterialization of the lower limbs

Frequently Asked Questions about Lumend

Lumend was founded in 1996 and raised its 1st funding round 7 years after it was founded.

Lumend is headquartered in Redwood City, United States. It is registered at Redwood City, California, United States.

Lumend is a funded company, having raised a total of $30.05M across 4 funding rounds to date. The company's 1st funding round was a Series D of $2M, raised on Jan 09, 2003.

Lumend was founded in 1996 in Redwood City, United States, focusing on medical devices in the cardiovascular sector. Catheter-based technologies are produced and developed to address chronic occlusions in coronary and peripheral artery disease. Devices that aid guide wire placement during invasive procedures, including angioplasty and stenting, are marketed to interventional cardiologists, radiologists, and vascular surgeons. The company was acquired by Cordis in 2005.

Lumend's top competitors include Contego Medical, Limflow and Shape Memory Medical.

Lumend has 7 investors. Key investors include Cordis, CHL Medical Partners, Morgenthaler, De Novo Ventures, and ABS Ventures.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available